Long-term use of daptomycin for MRSA osteomyelitis and joint infection

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 2, 2008, Pages 183-186

  Burns, Cheryl A ^a  

^a Ocala Regional Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; RIFAMPICIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTHROTOMY; ARTICLE; BACTERIAL ARTHRITIS; BACTERIAL STRAIN; BONE SCINTISCANNING; CASE REPORT; CREATININE BLOOD LEVEL; DOSE KIDNEY FUNCTION RELATION; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERANCE; DRUG WITHDRAWAL; ENZYME ASSAY; ENZYME BLOOD LEVEL; HUMAN; LACTIC ACIDOSIS; LOADING DRUG DOSE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYALGIA; NEPHROTOXICITY; OSTEOMYELITIS; OUTCOME ASSESSMENT; RASH; SIDE EFFECT; SYNOVECTOMY; TREATMENT DURATION; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; DAPTOMYCIN; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; OSTEOMYELITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 38149063813     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701633038     Document Type: Article

References (19)

1. Ciampolini, J. and Harding, KG. (2000) Pathophysiology of chronic bacterial osteomyelitis: Why do antibiotics fail so often?. Postgrad Med J, 76, pp. 479-483.
2. Trampuz, A. and Zimmerli, W. (2005) New strategies for the treatment of infections associated with prosthetic joints. Curr Opin Investig Drugs, 6, pp. 185-190.
3. Lazzarini, L., Lipsky, BA and Mader, JT. (2005) Antibiotic treatment of osteomyelitis: What have we learned from 30 y of clinical trials?. Int J Infect Dis, 9, pp. 127-138.
4. Darley, ES and MacGowan, AP. (2004) Antibiotic treatment of Gram-positive bone and joint infections. J Antimicrob Chemother, 53, pp. 928-935.
5. Rao, N. and Regalla, DM. (2006) Uncertain efficacy of daptomycin for prosthetic joint infections: A prospective case series. Clin Orthop Relat Res, 451, pp. 34-37.
6. Antony, SJ. (2006) Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severe bone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus. Scand J Infect Dis, 38, pp. 293-295.
7. Burns, CA. (2006) Daptomycin-rifampin for a recurrent MRSA joint infection unresponsive to vancomycin-based therapy. Scand J Infect Dis, 38, pp. 133-136.
8. Finney, MS, Crank, CW and Segreti, J. (2005) Use of daptomycin to treat drug-resistant Gram-positive bone and joint infections. Curr Med Res Opin, 21, pp. 1923-1926.
9. Arbeit, RD, Maki, D., Tally, FP, Campanaro, E. and Eisenstein, BI. (2004) The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis, 38, pp. 1673-1681.
10. Fowler Jr, VG, Boucher, HW, Corey, R., Abrutyn, E., Karchmer, AW and Rupp, ME (2006) Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med, 355, pp. 653-665.
11. Weinstein, MP, Stratton, CW, Hawley, HB, Ackley, A. and Reller, LB. (1987) Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis. Am J Med, 83, pp. 218-222.
12. Tuazon, CU. (1982) Teichoic acid antibodies in osteomyelitis and septic arthritis caused by Staphylococcus aureus. J Bone Joint Surg Am, 64, pp. 762-765.
13. Papadopoulos, S., Ball, AM, Liewer, SE, Martin, CA, Winstead, PS and Murphy, BS. (2006) Rhabdomyolysis during therapy with daptomycin. Clin Infect Dis, 42, pp. 108-110.
14. Echevarria, K., Datta, P., Cadena, J. and Lewis, JS. (2005) Severe myopathy and possible hepatotoxicity related to daptomycin. J Antimicrob Chemother, 55, pp. 599-600.
15. Kazory, A., Dibadj, K. and Weiner, ID. (2006) Rhabdomyolysis and acute renal failure in a patient treated with daptomycin. J Antimicrob Chemother, 57, pp. 578-579.
16. Cubist Pharmaceuticals (2006) Cubicin® (daptomycin for injection) prescribing information.
17. Oleson Jr, FB, Berman, CL, Kirkpatrick, JB, Regan, KS, Lai, JJ and Tally, FP. (2000) Once-daily dosing in dogs optimizes daptomycin safety. Antimicrob Agents Chemother, 44, pp. 2948-2953.
18. Veligandla, SR, Louie, KR, Malesker, MA and Smith, PW. (2004) Muscle pain associated with daptomycin. Ann Pharmacother, 38, pp. 1860-1862.
19. Benvenuto, M., Benziger, DP, Yankelev, S. and Vigliani, G. (2006) Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother, 50, pp. 3245-3249.